{
    "text": "NKX2-1 expression impacts prognosis in early-stage NSCLC patients, particularly in those with neither TP53 nor KRAS mutations.", 
    "denotations": [
        {
            "id": "T1", 
            "obj": "NKX2-1", 
            "span": {
                "begin": 0, 
                "end": 6
            }
        }, 
        {
            "id": "T1", 
            "obj": "NSCLC", 
            "span": {
                "begin": 51, 
                "end": 56
            }
        }, 
        {
            "id": "T1", 
            "obj": "TP53", 
            "span": {
                "begin": 102, 
                "end": 106
            }
        }, 
        {
            "id": "T1", 
            "obj": "KRAS", 
            "span": {
                "begin": 111, 
                "end": 115
            }
        }
    ],
    "relations": [
        {
            "id":"R1",
            "pred":"causes",
            "subj":"T2", 
          "obj":"T1"}
    ]
}
